Series |
TOPICS |
Title |
First trough level of infliximab at week 2 predicts outcomes of induction therapy in ulcerative colitis -- results from a multicenter prospective randomized controlled trial and its post hoc analysis |
Author |
Taku Kobayashi |
Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
Author |
Yasuo Suzuki |
Department of Internal Medicine, Toho University Sakura Medical Center |
Author |
Satoshi Motoya |
Inflammatory Bowel Diseases Center, Sapporo-kosei General Hospital |
Author |
Fumihito Hirai |
Department of Gastroenterology, Fukuoka University Chikushi Hospital |
Author |
Haruhiko Ogata |
Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine |
Author |
Hiroaki Ito |
Kinshukai Infusion Clinic |
Author |
Mamoru Watanabe |
Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University |
Author |
Toshifumi Hibi |
Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital |
[ Summary ] |
No Summary |